Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7595345 Vitamin D receptor modulators

Patent 7595345 was granted and assigned to Eli Lilly on September, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Emilio Enrique Bunel0

Charles David Jones0

Jianliang Lu0

Robert Peter Gajewski0

Sunil Nagpal0

Tianwei Ma0

Ying Kwong Yee0

Date of Patent

September 29, 2009

Patent Application Number

10579562

Date Filed

November 16, 2004

Patent Citations Received

US Patent 11779550 Bisphenol ether derivatives and methods for using the same

US Patent 12109179 Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof

0

US Patent 11919874 Bisphenol derivatives and their use as androgen receptor activity modulators

0

Patent Primary Examiner

Sharmila Gollamudi Landau

Patent abstract

The present invention relates to novel, non-secosteroidal, hydroxyl substituted, carbon-linked diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7595345 Vitamin D receptor modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool